Capital Impact Advisors, LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 97 filers reported holding CTI BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2014$128,000
-2.3%
54,2000.0%0.06%
Q3 2014$131,000
+72.4%
54,200
+100.0%
0.00%
-100.0%
Q2 2014$76,00027,1000.06%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2015
NameSharesValueWeighting ↓
FIRST NEW YORK SECURITIES LLC /NY 191,000$345,710,0000.34%
TFS CAPITAL LLC 1,182,304$2,140,0000.21%
TURNER INVESTMENTS LLC 530,100$959,0000.17%
DRW Securities, LLC 486,953$881,0000.14%
Candriam S.C.A. 1,445,000$2,616,0000.05%
First Heartland Consultants, Inc. 74,624$135,0000.05%
WASHINGTON TRUST Co 410,616$743,0000.05%
EAGLE ASSET MANAGEMENT INC 4,332,630$7,842,0000.04%
JW Asset Management, LLC 52,271$95,0000.04%
OXFORD ASSET MANAGEMENT LLP 702,571$1,272,0000.03%
View complete list of CTI BIOPHARMA CORP shareholders